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ABSTRACT 
 
BACKGROUND: The prevalence of pre-diabetes and diabetes along with concomitant low-
grade systemic inflammation continues to increase, particularly as a consequence of excess 
body weight.  Physical activity (PA) has been examined as a preventive intervention against 
these conditions primarily through its role in weight reduction.  It remains unknown, however, if 
individuals of normal weight who do not engage in regular physical activity are at increased risk 
for pre-diabetes.  
 
METHODS: A cross-sectional analysis was conducted of n=6085 participants from the National 
Health and Nutrition Examination Survey (NHANES) annual surveillance surveys conducted 
from 2001-2006, who met the following criteria: 20-64 years, disease-free (self-report of no 
diabetes, asthma, arthritis, CHD, angina, stroke, emphysema, chronic bronchitis, and cancer), 
and non-smoker. Three self-reported measures of physical activity (PA) in the past 30 days, the 
independent variable, were assessed: (1) Intensity Level (moderate or vigorous); (2) Agreement 
with the American College of Sports Medicine (ACSM) guidelines for frequency, intensity, and 
time/duration (FIT) of PA (i.e., ≥ 5 days per week of moderate intensity PA for ≥ 30 min, or,  ≥ 3 
days per week of vigorous intensity PA for ≥ 20 min); and, (3) ACSM recommendations for 
MET-Mins Per Week (i.e., total work expenditure of specific activities engaged in by 
participants) of 500–1000 MET-Mins Per Week.  Logistic Regressions (Crude and Age-Sex 
Adjusted) were performed between each of the three PA measures in relation to the following 
two dependent variables that reflect pre-diabetes status: 1) sex-specific elevated waist 
circumference (≥ 40 in for men and ≥ 35 in for women); and, (2) homeostatic model assessment 
for insulin resistance (HOMA-IR) using an established cutpoint of >2.2).  Exploratory analyses 
were performed of immune system cells as markers of low-grade systemic inflammation in 
relation to the dependent variables.  We assessed relationships separately among individuals 
who were of normal weight, overweight and obese to determine if the benefits of PA are 
reduced among the latter two groups due to, presumably, the burden of excess body weight.   
 
RESULTS: Elevated waist circumference was inversely associated with vigorous intensity level 
PA, compared to referent group, among those with a normal weight (Crude OR 0.33, 95% CI 
0.22-0.51) and overweight (Crude OR 0.50, 95% CI 0.41-0.62).  No such association was 
observed for moderate intensity and elevated waist circumference.  Adjusted odd ratios (ORs) 
persisted among only the normal weight group.  Elevated waist circumference also was 
inversely associated (Crude ORs) with the highest level of MET-Mins Per Week (≥ 500) and 
those who met ACSM guidelines for FIT criteria among both the normal and overweight in crude 
analyses.  These associations were maintained in adjusted analyses for the most part.  
Regarding immune function, those who reported a vigorous intensity or those who met ACSM 
weekly guidelines exhibited an inverse correlation with levels of white blood cell count, 
segmented neutrophil percent and segmented neutrophil number. A direct correlation, however, 
was observed with lymphocyte percent, monocyte percent, and basophil percent with MET-Min 
Per Week.  While findings suggested an inverse relationship between PA and HOMA, few tests 
were statistically significant. 
 
CONCLUSIONS:  Among the normal weight, an elevated waist circumference was far less likely 
among those who engaged at the highest levels of PA.  Similarly, for elevated HOMA, data 
suggested that higher levels of PA among those of normal weight were associated with a 
reduced chance of exhibiting insulin resistance, but findings did not reach statistical 
significance. Data suggests a positive relationship between White Blood Cells and having an 
Elevated Waist Circumference among females who were of normal weight but not so among 
their male counterparts.  Findings regarding the benefits of PA in relation to insulin resistance, 
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however, were not consistent possibly owing to low prevalence of this state in the study sample.  
Future research is recommended to confirm our findings with objective measures of PA, such as 
an accelerometer, and to clarify divergent results regarding immune system cells. 
 
1 
 
 INTRODUCTION 
 
1.1 Burden of Pre-diabetes and Diabetes  
 
Among adults aged 20 years or older in the United States, 25.6 million or 11.3% have 
diabetes, with an additional 79 million people having the pre-cursor state of prediabetes1.  In 
2007, diabetes was listed as the underlying cause on 71,382 death certificates, and listed as a 
contributing factor on an additional 160,022 death certificates; contributing to a total of 231, 404 
deaths in 20071.  Diabetes contributes to many complications including heart disease and 
stroke, high blood pressure, blindness, kidney disease, neuropathy, amputation, and certain 
cancers.  Type 2 diabetes, which accounts for about 95% of diagnosed diabetes in adults, is 
incurable once the disease is achieved.  Although individuals with prediabetes are at 
substantially increased risk of developing Type 2 Diabetes, the onset can be prevented or 
delayed by losing 5-7% of their body weight and expending at least 150 minutes per week of 
moderate intensity physical activity2.  Pre-diabetes is defined as having blood glucose levels 
that are higher than normal, but not high enough to be diagnosed as diabetes (i.e. fasting 
glucose >100 mg/dl).  It is estimated that 33% of U.S. adults have prediabetes, although 
awareness of this condition is low2.  
The metabolic syndrome (MetS), another pre-cursor state for diabetes, affects millions 
nationwide, with the prevalence increasing with age and body mass index (BMI)3.  
Epidemiological studies have reported an increased prevalence of the syndrome worldwide4, 
posing significant health problems with the global epidemic of overweight and sedentary 
lifestyle5.  About 34% of adults in the U.S. (> 20 years of age) meet the criteria for metabolic 
syndrome3.  The metabolic syndrome is a constellation of risk factors that places individuals at 
an increased risk for not only Type 2 Diabetes but cardiovascular disease (CVD), polycystic 
ovary syndrome, fatty liver, cholesterol gallstones, asthma, sleep disturbances, and some forms 
of cancer6.  The most commonly used clinical definition of the Metabolic Syndrome is derived 
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from National Cholesterol Education Program’s Adult Treatment Panel III (ATP III), which 
specifies that three of the following five criteria must be met: abdominal obesity (men > 40in, 
women >35in), elevated triglycerides (≥ 150mg/dL), low HDL cholesterol (men <40mg/dL, 
women <50mg/dL), hypertension (≥135/85mmHg), and high fasting glucose(≥100mg/dL)3.  The 
core pathophysiology of MetS is abdominal adiposity and insulin resistance7, the latter being 
considered a pre-diabetic state.  The chief characteristic of insulin resistance is hyperglycemia, 
which reflects reduced uptake of insulin by cells resulting in a buildup of excess glucose in the 
bloodstream.  In fact, the majority (78%) of people who have the MetS are insulin resistant7. 
 
1.2 Physical Activity and Pre-Diabetes 
ATP III has recommended incorporating physical activity for weight loss and the 
reduction of insulin resistance6.  The difficulty in determining the effect of exercise independent 
of weight loss has made exercise prescription unclear, although dose-dependent trends display 
increasing levels of physical activity lowering the incidence of the MetS and higher levels of 
physical activity protecting against the development of the MetS7. The incidence of the MetS is 
twice as high in adults reporting no moderate or vigorous intensity physical activity compared 
with those reporting engaging in at least 150 min/wk7, 8.  LaMonte and colleagues have shown 
that the MetS incidence was lower in middle-aged women and men with higher cardiorespiratory 
fitness when followed in a prospective study for an average of 5.7 years9.   
Physical activity has been shown to reduce insulin sensitivity, dyslipidemia, and 
hypertension even among obese/overweight people who have not lost weight7.  Exercise 
improves glucose homeostasis by enhancing glucose transport and insulin action in working 
skeletal muscle during muscle contraction by stimulating glucose uptake. In addition, after a 
single bout of aerobic exercise, sensitivity to insulin-mediated glucose uptake is greatly 
improved immediately after exercise10, 11.  Repeated bouts of exercise that are accompanied by 
improvements in cardiorespiratory fitness (i.e., aerobic exercise training), do not appear to 
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improve glucose uptake beyond the effect of the last bout of exercise independent of change in 
body weight12.  Segal et al suggested for the continued benefit of exercise on insulin action, an 
individual would need to follow the American College of Sports Medicine (ACSM) and Centers 
of Disease Control and Prevention (CDC) recommendations to engage in 150 minutes of 
moderate-intensity aerobic activity or 75 minutes of vigorous-intensity aerobic activity every 
week13. Evidence suggests that aerobic training may need to be accompanied by weight loss for 
an effective change in insulin sensitivity beyond the immediate post exercise effects7.  
 
1.3   American College of Sports Medicine Physical Activity Recommendations  
 Several studies have supported a dose–response relationship between regular physical 
activity and health outcomes14, 15.  Epidemiologic studies have estimated that the volume of 
physical activity needed to lower rates of CVD and premature mortality related to cardiac health 
and diabetes is:  moderate intensity physical activity for about 150 min/wk; OR; vigorous-
intensity exercise performed for a total of 75 min/wk16. 
Another way to measure energy expenditure is by the metabolic equivalent (MET), which 
is the ratio of the rate of energy expended during one minute of activity at rest16.  The 
recommended target volume in MET/min/wk is 500–1000 MET/min/wk16.   
 
1.4 Inflammation in Pre-Diabetes and Diabetes 
Low grade inflammation is present in the pathogenesis of certain metabolic disorders 
such as insulin resistance, the metabolic syndrome, and adult-onset diabetes17. Inflammation is 
secondary to the activation of the acute phase response of the innate immune system which 
respond to tissue damage and infection17.  Immune cells such as macrophages, lymphocytes, 
and eosinophils have been implicated as playing a role in this process18-24.  Neutrophils, the first 
immune cells to respond to inflammation, promote a more chronic inflammatory state by 
secreting several proteases, specifically neutrophil elastase18, 25.   
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White blood cells (include e.g., basophils, eosinophils, monocytes, neutrophils, and 
lymphocytes) help fight infections when the body encounters a foreign invader, producing a 
generalized, non-specific reaction known as inflammation26.  Activation of the innate immune 
pathways has been implicated in the pathogenesis of insulin resistance; however, these 
pathways are also closely linked to changes in lipid deposition27.  White Blood Cell (WBC) count 
is elevated in those with obesity and impaired glucose tolerance, such as pre-diabetes and 
diabetes18.  Specifically, neutrophils in adipose tissue are associated with a marked increase in 
neutrophil elastase release, which may contribute to cellular insulin resistance; this is supported 
by the observation that inhibiting elastase improved insulin resistance18.  Also, Talukdar and 
others suggest that neutrophils, particularly the associated neutrophil elastase release, promote 
the metabolic syndrome18. 
 
1.5 Physical Activity and Inflammation 
 High intensity aerobic training has been found to be effective in reducing low-grade 
inflammation in people with metabolic syndrome28.  In a NHANES III study, more frequent 
physical activity (i.e, measured by engagement in 9 activities in last 30 days) was associated 
with lower prevalence of inflammation (e.g., C-reactive protein) among healthy US adults 
(exclusion of individuals with self-reported diabetes, asthma, arthritis, CHD, angina, stroke, 
emphysema, chronic bronchitis, and a personal history of cancer)29.  Also aerobic and 
resistance training also have been reported to reduce circulating levels of inflammation30.  
First-degree relatives of patients with Type 2 Diabetes may exhibit a disproportionately 
elevated risk of insulin resistance, obesity, and Type 2 Diabetes as a  
result of physical inactivity, which in part, might be due to low-grade inflammation31.  The key 
finding of Hojbjerre et al, 2011 is that nonobese, insulin-resistant individuals with a family 
predisposition for Type 2 Diabetes exhibited low-grade inflammation and, notably, as little as 10 
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days of physical inactivity negatively affected the condition and exhibited insulin sensitivity in 
response to bed rest31.  
 
1.6   Research Aims  
Assessing the relationship between physical activity and insulin resistance among 
individuals of normal weight provides an opportunity to examine the health benefits independent 
of body fat reduction.  Further, the prevalence of insulin resistance in normal weight individuals 
has not been well studied.  The primary aim of this study is to determine, among the normal 
weight, if the prevalence of insulin resistance is greater among those who engage in less 
physical activity.  Secondly, we will assess this relationship among individuals who are 
overweight and obese to determine if the benefits of physical activity are reduced due to, 
presumably, the burden of excess body weight. Our third aim is to assess waist circumference, 
and inflammation measured by  
immune system cell function as the dependent variables in relation to physical activity. 
 
2.0 METHODS 
2.1 Study Population in NHANES 
Data from the National Health and Nutrition Examination Survey (NHANES) annual data 
from 2001 to 2006 were analyzed. NHANES is a program of the Centers for Disease Control 
and Prevention (CDC) that collects the health and nutritional status of adults and children in the 
United States32.  The survey examines a nationally representative sample, combining interviews 
and physical and laboratory examinations to determine the prevalence of major diseases and 
risk factors for diseases32.  A complex statistical process using the most current Census 
information selects persons from a broad range of age groups and racial/ethnic backgrounds.  
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NHANES participants are a nationally representative sample of a civilian, 
noninstitutionalized US population, selected by using a multistage, stratified sampling design. A 
complete description of the NHANES sampling design and recruitment process has been 
published previously33.  All participants were interviewed at home and subsets were invited to 
mobile examination centers for additional questionnaires, physical examinations and laboratory 
measures.  The NHANES protocol was approved by the National Center for Health Statistics’ 
Institutional Review Board (IRB) and all participants provided informed consents32. 
 
 
2.2 Eligibility Criteria 
 
Individuals who participated in the National Health and Nutrition Examination Survey 
(NHANES) from 2001 to 2006 were determined to be eligible for this study if they were: 20 to 64 
years of age and non-smokers (i.e., never or former).  Body Mass Index (BMI) was calculated 
as kg/m2.   Individuals classified as underweight (BMI < 18.50) were excluded as were those 
missing BMI status.  The following three categories of BMI were used to classify excess body 
weight:  Normal (18.51-24.99), Overweight (25.00-29.99), and Obese (≥ 30.00.)34.   
Individuals were excluded with conditions that could affect inflammation levels as well as 
one’s ability to engage in physical activity, as used in several prior similar studies29. These 
conditions (self-report) were: diabetes, asthma, arthritis, coronary heart disease, angina, stroke, 
emphysema, chronic bronchitis, and a personal history of cancer.  
Smoking status was determined based on the question “Do you now smoke cigarettes” 
or “Have you previously smoking cigarettes”. We excluded individuals with diabetes whose 
fasting glucose was greater than 100 mg/dL. From the initial sample population of 31,485 from 
the NHANES 2001- 2006 annual data, our study included  
6,085 participants who met all the inclusion and exclusion criteria.  Subgroups were selected to 
attend the mobile examination centers for more laboratory testing, which consisted of: insulin 
(n=2814), glucose (n=4119), cholesterol (n=5755), and white blood cell counts (n=5804). 
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2.3 Physical Activity Measures 
 
Intensity Level 
Intensity was defined as: vigorous, moderate and no vigorous or moderate activity. To 
determine intensity level, NHANES questioned participants “Over the past 30 days, did you do 
any vigorous activities for at least 10 minutes that caused heavy sweating, or large increases in 
breathing or heart rate?” Examples provided for vigorous activities in the survey included 
running, lap swimming, aerobics classes, or fast bicycling. Respondents were also asked “Over 
the past 30 days, did you do moderate activities for at least 10 minutes that caused only light 
sweating or a slight to moderate increase in breathing or heart rate?” Examples provided for 
moderate activities in the survey included brisk walking, bicycling for pleasure, golf, and 
dancing. Participants who answered ‘yes’ to either intensity were included in the ‘vigorous ’or 
‘moderate’ physical activity group. Participants who responded in the affirmative to both 
questions were included in the ‘vigorous’ physical activity, whereas those who answered both 
questions in the negative were included in the ‘neither’ category for physical activity. This 
category was labeled ‘intensity level’ in analyses. 
 
ACSM Frequency, Intensity, and Time Guidelines for Exercise (FIT) 
American College of Sports Medicine (ACSM) provides recommendations for moderate 
and vigorous exercise16. The recommendations include performing at least 5 days per week of 
moderate intensity physical activity for 30 minutes or more, or at least 3 days per week of 
vigorous intensity physical activity for 20 minutes or more, or a combination of both16.  
Individuals were interviewed about specific individual moderate and vigorous leisure-time 
activities. For each reported leisure-time activity, participants were asked to report:  intensity as 
moderate (see definition above) or vigorous (see definition above), number of times the activity 
was carried out during the past 30 days, and average number of minutes the activity was done. 
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Activities with a reported total time per day of 12 hours or more were excluded from analyses32. 
For example, if bowling was reported an average of 3 times a day for an average of 4 hours 
each time, the person was re-classified as having engaged in no activities.  
ACSM weekly guidelines differ for aerobic and non-aerobic activities16.  Hence, we 
placed non-aerobic activities in a separate level in the FIT variable. Non-aerobic activities 
included flexibility, resistance training activities, and other activities that could not be classified 
as cardiovascular. Please visit Figure 2 for a breakdown of the individual physical activities into 
aerobic and non-aerobic groups. 
ACSM MET-Minutes Per Week Recommendations 
The total metabolic equivalent score (MET score) was calculated for each week based 
on the information from the individual activities, using the Ainsworth Compendium35.  MET-
Minutes is an index of energy expenditure that quantifies the total amount of physical activity 
(i.e., volume) performed in a standardized manner across individual activities16.  Metabolic 
equivalent scores (METs) are a useful, convenient, and standardized way to describe the 
absolute intensity of a variety of physical activities.  Light physical activity is defined as requiring 
≤ 3 METs, moderate as 3–6 METs, and vigorous as ≥ to 6 METs31. MET score or MET-Minutes 
Per Week is calculated as the product of the number of METs associated with one or more 
physical activities and the number of minutes the activities was performed per week or per day. 
Example: jogging (at 7 METs) for 30 min on 3 d/wk would equal:  7 METs *30 min* 3d/week = 
630 MET/min/wk31.  
The categories of MET-minutes per week for vigorous and moderate activities included 
no moderate or vigorous activity reported, ≤  250 MET-mins/wk, 250-499 MET-mins/wk, and ≥ 
500 MET-mins/wk. These categories were created to distinguish amount of MET-Minutes 
needed to induce outcome changes. As stated previously, the ACSM recommended target 
volume in MET/min/wk is 500–1000 MET/min/wk16. 
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2.4 Outcomes   
Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) 
HOMA-IR is a mathematical equation to calculate insulin resistance using fasting 
glucose and insulin values as follows:  [Glucose (mmol/L), X Iinsulin (uU/mL)] / divided by 
22.5]37.  Values of 2.2 and greater signify insulin resistance36. 
Several techniques are available for measuring insulin resistance, including the 
hyperinsulinemic-euglycemic clamp technique, the intravenous glucose tolerance test, and the 
insulin suppression test. However, these techniques are complicated and not suitable for large-
scale population studies or routine clinical work, therefore simpler clinical measurements have 
been proposed for assessing insulin resistance such as HOMA37, 38.  
Waist Circumference 
An elevated waist circumference was defined as measuring greater than or equal to 40 
inches for men and 35 inches for women34.  Waist Circumference was determined by measuring 
the circumference of the abdomen (cm) at the natural waist, around the bellybutton, and was 
classified as ‘elevated’ for males at >102 cm and females at >88 cm.  
Low-Grade Systemic Inflammation: Immune System Cells 
Several cells of the immune system were assessed to approximate if inflammation levels 
varied in relation to the physical activity measures, as evidence of metabolic disturbance: white 
blood cell count, lymphocyte percentage and number, monocyte percentage and number, 
segmented neutrophils percentage and number, eosinophils percentage and number, and 
basophils percentage and number.  Mean values for all markers will be obtained to determine 
relationship with physical activity level. 
The technique used by NHANES to collect blood samples is detailed elsewhere39.  
Exclusion criteria for laboratory analyses were: hemophiliacs, participants who received 
chemotherapy within last 4 weeks, the presence of the following on both arms: rashes, gauze 
dressings, casts, edema, paralysis, tubes, open sores or wounds, withered arms or limbs 
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missing, damaged, sclerosed or occluded veins, allergies to cleansing reagents, burned or 
scarred tissue, and shunt or IV39. 
 
  
2.5 Statistical Analyses 
 
Pearson Chi-squared Test, and the Spearman and Pearson Coefficients of Correlation 
were calculated for descriptive analyses.  Univariate and Age and Sex Adjusted Logistic 
regression analysis were performed.  Analyses were stratified by BMI status (Normal, 
Overweight, Obese).  Results for all tests were considered statistically significant if p<0.05 or if 
confidence intervals (95%) did not include the value of 1.0.  SPSS ver. 20.0 was used to 
perform all statistical analyses. 
 
3.0 RESULTS 
 
3.1 Participant Characteristics according to BMI Group 
 Participant characteristics are reported in Table 1.  Individuals who were of normal 
weight tended to be younger than the overweight and obese groups (Mean ages of 36.31, 
40.38, and 41.15, respectively, p<.001).  Compared to the obese group, the normal weight 
group contained a greater percentage of college graduates and females, and fewer non-
Hispanic Blacks and Mexican Americans. 
Individuals with normal weight were far more likely to exhibit a normal HOMA Index 
compared to the obese group (46.6% and 15.3%, respectively, p<.001). The number of people 
who were classified as having the metabolic syndrome increased with increasing BMI group, but 
there were a significant number of people with missing data of two or more of the components 
(41.5%, p<.001). 
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White blood cell count, numbers of lymphocyte, monocyte, segmented neutrophils, 
eosinophils, and basophils, display a positive linear trend with increasing BMI (p<.001). In 
contrast, percent of monocyte displayed a negative inverse trend with increasing BMI (p<.001).  
Percent of lymphocyte, segmented neutrophils, eosinophils, and basophils did not vary 
according to weight status. 
3.2 Participant Characteristics according to PA Measures  
Intensity Level 
 As seen in Table 2-A, compared to those who did not engage in either moderate or 
vigorous intensity physical activity in the past 30 days,  individuals who reported engaging in 
vigorous intensity leisure time activities were more likely to be male (30.8% versus 46.0%, 
respectively, p < .001), and slightly younger (40.26 versus 37.69, respectively, p<.001).  Those 
who reported engaging in vigorous intensity physical activities were less likely to exhibit the 
metabolic syndrome compared to those who engaged in moderate intensity activities or no such 
activities during the time period (28.55%, 32.7%, 38.8%, respectively, p < .001).  Similarly, 
mean HOMA was greater among those who did not engage in any leisure time activities 
compared to those who engaged in moderate or vigorous intensity physical activities (3.66 and 
2.64, respectively, p <.001).   
White blood cell count, percent of lymphocyte, eosinophils, monocyte, and segmented 
neutrophils, and numbers of lymphocyte and segmented neutrophils all displayed lower values 
in the vigorous intensity group when compared to those who engaged in no moderate or 
vigorous intensity activities.  However, in these cells the moderate intensity group displayed 
higher immune system cell values compared to the no activity group.  In post hoc comparisons, 
only percent of lymphocyte and segmented neutrophils, and numbers of segmented neutrophils 
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between the no physical activity group and moderate intensity physical activity group were 
statistically significant.  
Frequency, Intensity, and Time (FIT) 
As reported in Table 2-B, among individuals who engaged in moderate or vigorous 
intensity activities in the past 30 days, those who met the ACSM guidelines (i.e., ≥ 5 days per 
week of moderate intensity PA for ≥30 minutes; or ≥3 days per week of vigorous intensity 
physical activity for ≥20 minutes) were slightly younger (38.71 vs 40.39, respectively, p<.001), 
more likely to be male (17.9% vs 15.3%, respectively, p<.001), and had lower rates of the MetS 
(14.2% vs 39.4%, respectively, p<.001) when compared to the group who did not engage in 
such activities.  Mean HOMA-IR was lower (2.59) among individuals who reached the ACSM 
recommended level of activity compared to those in the other three FIT groups: who engaged in 
some level of moderate or vigorous intensity activity during the time period, only non-aerobic 
activities,  or those who did not engage in such activities  (2.98, 3.13 and 3.74, respectively,  
p<0.001).  Participants who met the ACSM guidelines exhibited lower levels of,  WBC count, 
percent of monocyte and basophils, and numbers of segmented neutrophil and eosinophil 
compared to the other three PA groups (P <0.001).  In contrast, monocyte number and 
basophils percent did not vary according to PA FIT group. 
MET-Minutes per Week  
As reported in Table 2-C, individuals who expended greater than 500 MET-Mins Per 
Week were slightly younger than those who engaged in no moderate or vigorous activities in the 
past 30 days (38.87 vs 40.39, respectively, p<.001), more likely to be male (49.9% vs 31.3%, 
respectively, p <.001), and exhibited reduced mean HOMA values (2.76 vs 3.74, respectively, 
p<.001) and metabolic syndrome (35.0 vs 39.4, respectively, p<.001).  Significant differences in 
immune system cell function were only seen between individuals in groups who exceeded 500 
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MET-Mins Per Week when compared to the group who reported no physical activities for white 
blood cell count, percent of lymphocyte and segmented neutrophils, and number of   
lymphocyte, segmented neutrophils, and eosinophils . Conversely, percent of monocyte  and 
basophils  displayed increasing numbers with an increase in MET-Mins Per Week.  
 
3.3 ORs for At-Risk Waist Circumference and Elevated HOMA in relation to PA 
Waist Circumference 
Intensity Level 
 For these analyses, the obese group was eliminated because the vast majority (e.g., 
61.2%) of individuals in this group had an elevated waist size.  As seen in Table 4, among those 
of normal weight and overweight, individuals who reported engaging in vigorous physical activity 
in the past 30 days displayed a significant decrease in elevated waist (Age and Sex-Adjusted 
OR=0.37, 95% CI=0.24-0.57; OR=0.65, 95% CI=0.52-0.83) compared to both the no activity 
group and moderate intensity group. As displayed, the benefits of physical activity were 
observed even among the normal weight, thus reducing the risk for pre-diabetes.  
Frequency, Intensity, and Time (FIT) 
In Table 4, both normal weight and overweight individuals displayed a decreased risk for 
elevated waist circumference if they engaged in either non-aerobic activities or aerobic activities 
that met or did not meet the ACSM guidelines. Those normal weight and overweight individuals 
who did meet the ACSM guidelines (i.e., ≥ 5 days per week of moderate intensity PA for ≥30 
minutes; or ≥3 days per week of vigorous intensity physical activity for ≥20 minutes), displayed 
greater decreases in risk (Age and Sex-adjusted OR=0.60, 95%CI=0.37-0.98; OR=0.62, 95% 
CI=0.45-0.84) when compared to the group who did not meet the guidelines.  
MET-Min per Week 
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 In Table 4, individuals with normal weight or overweight displayed a reduced likelihood 
for having an elevated waist only at the highest level of PA volume.  (i.e., >500 MET-Mins Per 
Week.), which was maintained in adjusted analyses (OR=0.52, 95% CI=0.36-0.77; OR=0.72, 
95% CI=0.57-0.90, respectively.).  
HOMA 
Intensity Level 
 As seen in Table 4, among those with normal weight, individuals who reported engaging 
in vigorous physical activity in the past 30 days, were less likely to have an elevated HOMA 
value (>2.2) compared to those who did not engage in any such activities but did not reach 
statistical significance (Adjusted OR=0.70, 95% CI=0.45-1.09).  The OR in relation to moderate 
intensity physical activities also was not suggestive of a preventive effect (OR 0.92, 95% CI = 
0.58-1.46).  Similar trends were observed among individuals who were overweight. In contrast, 
among those with obesity, engaging in either moderate or vigorous intensity physical activities 
was associated with a significantly reduced likelihood of elevated HOMA (Age and Sex-adjusted 
OR = 0.66, 95% CI = 0.45-0.96; Age and Sex-adjusted OR =0.59, 95% CI = 0.40-0.87), 
compared to obese individuals who did not engage in any such activities. 
Frequency, Intensity, and Time (FIT) 
Among individuals with normal weight in Table 4, those who met the ACSM guidelines 
(i.e., ≥ 5 days per week of moderate intensity PA for ≥30 minutes; or ≥3 days per week of 
vigorous intensity physical activity for ≥20 minutes) had a reduced risk for elevated HOMA (Age 
and Sex-adjusted OR=0.69, 95% CI=0.39-1.22) compared to the group who did not engage in 
any activity. Individuals, who engaged in physical activity but did not meet the ACSM guidelines, 
displayed a reduced risk for elevated HOMA. This reduced risk was to a lesser extent compared 
to the group who met the ACSM physical activity guidelines. Similar trends were observed for 
the overweight. In contrast, the obese engaging in any activity, either not meeting the ACSM 
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guidelines or meeting the guidelines, displayed a significantly reduced likelihood of elevated 
HOMA (Age and Sex-Adjusted OR=0.61, 95% CI=0.43-0.86; OR=0.60, 95% CI=0.38-0.96). 
 
MET-Min Per Week 
 In Table 4, the normal weight, overweight, and obese displayed decreased risks for 
elevated HOMA when compared to the group who did not engage in any such activity. Although 
all groups had a decreased risk in all MET-Mins  Per Week categories, the obese group had 
the most significant decline in risk for all MET-Mins Per Week groups <250, 250-499, and >500 
(Age and Sex-Adjusted OR=0.67, 95% CI=0.43-1.06; OR=0.59, 95% CI=0.34-1.03; OR=0.59, 
95% CI=0.41-0.84).  
 
3.4 Partial Correlation Coefficients of Immune Cells with Waist Circumference and MET-
Mins per Week according to BMI Group 
Waist Circumference 
 A positive correlation between waist circumference and white blood cell count was 
observed among the normal weight, overweight and obese (0.213, p<.001; 0.209, p<.001; 
0.204, p<.001, respectively) controlling for age.  This same pattern was observed in relation to 
percent segmented neutrophils (0.164, p<.001; 0.179, p<.001; 0.100, p=0.002, respectively).  
Percent lymphocyte, however, displayed an inverse correlation with waist circumference across 
the weight groups (-0.180, p=0.000; -0.202, p=0.000; -0.103, p=0.002, respectively).  
MET-Mins Per Week 
 Among both normal and overweight individuals, white blood cell count displayed an 
inverse relationship (-0.119, p=0.001; -0.085, p=0.006), while percent monocyte (0.151, p<.001; 
0.105, p=0.001) displayed a positive relationship. Individuals with normal weight also displayed 
a significant inverse relationship for percent segmented neutrophils (-0.117, p=0.001).  The 
obese displayed no correlation to any of the immune system cells for MET-Mins Per Week. 
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3.5 Partial Correlation Coefficients of Immune System Cells with Waist Circumference: 
Stratified by BMI and Sex   
 Exploratory analyses identifying correlations of WBCs with waist circumference were 
further stratified by gender owing to reported physiological consequences with regard to sex and 
central adiposity40.  Analyses were restricted to WBCs to avoid false-positive findings stemming 
from multiple tests.  Among individuals of normal weight, a strong positive correlation was 
observed with waist circumference among females but not males in relation to waist 
circumference and WBC count (rP =0.309, p=<.001; rP =0.01, p=0.80, respectively.)  Among the 
overweight and obese, significant positive correlations (rP =0.16 to 0.22) were found for both 
males and females (See Table 6.)     
 
4.0 DISCUSSION 
 
 Among the normal weight, having an elevated waist circumference was far less likely 
among those who engaged at the highest levels of PA (vigorous intensity level, met ACSM FIT 
guideline, and ≥ 500 MET-Min Per Week.  This relationship also was observed among the 
overweight and obese but to a lesser extent.  Findings regarding the benefits of PA in relation to 
insulin resistance, however, were not consistent possibly owing to low prevalence of this state in 
the study sample.  
 
Waist Circumference.  The strongest associations with PA were observed with elevated waist 
circumference.  For example, individuals of normal and overweight engaging in vigorous 
physical activity showed a decreased risk in elevated waist circumference compared to both the 
no activity and moderate intensity group. Also, overweight individuals who engaged in any 
activity (whether or not they met the ACSM physical activity guidelines of ≥ 5 days per week of 
moderate intensity PA for ≥30 minutes; or ≥3 days per week of vigorous intensity physical 
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activity for ≥20 minutes), and in both normal and overweight individuals who engaged in >500 
MET-Mins Per Week displayed lower risk for elevated waist.  
Our results suggest that, even among the normal weight individuals, physical activity can 
help prevent an elevated waist circumference, a major risk factor for disease.  Our findings are 
consistent with a number of prior studies. Hamer and colleagues (2013) reported that regular 
physical activity, particularly vigorous intensity, was associated with a smaller waist 
circumference41.  Stamatakis et al (2009) displayed that sedentary behavior, measured in 
television time per day, was associated with increased waist circumference independent of 
engagement in physical acivity42.   
Although our study has shown an increased benefit in engaging in vigorous physical 
activity, the risk of exercise increases including an increased risk of musculosketal injury and 
cardiovascular complications which include cardiac arrest or sudden death43.  It is important to 
obtain medical clearance before engaging in any type of physical activity. 
 
HOMA.  Health benefits from PA associated with insulin resistance were suggestive but not 
definitive.  For example, prevalence of HOMA was lower among all weight groups (normal, 
overweight, and obese) for both moderate intensity and vigorous intensity groups compared to 
participants who engaged in no physical activities. This association was statistically significant 
only among the obese, however.   
Given that absolute prevalence of HOMA was low among the normal and overweight in 
our study, HOMA as an outcome appears to be a less sensitive reflection of the benefits 
regarding physical activity.  Nonetheless, the general tendency for reduced insulin resistance in 
a possible dose-response manner in relation to increased physical activity is consistent with 
prior studies.  Adams et al (2013) states that although moderate intensity exercise improves 
blood glucose levels, the total volume needed is difficult to achieve, making brief bouts of high 
intensity exercise favorable43.  In a review by Adams et al, two weeks of high intensity exercise 
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(either by cycle ergometer or sprinting) improved insulin sensitivity 1 to 3 days post-exercise in 
nondiabetics when compared to a sedentary group44.  This suggests that health-related benefits 
still occur at a higher intensity level of physical activity comparable to moderate intensity. 
Janssen and Ross (2012) used accelerometer data from 2003-04 and 2005-06 cycles of 
NHANES which displayed lower rates of the metabolic syndrome with vigorous intensity 
exercise independent of physical activity dose measured in energy expenditure45.  There is a 
growing body of literature that supports the additional benefits of vigorous exercise in all-cause 
mortality, cardiovascular risk, and diabetes when compared to moderate intensity physical 
activity46-48.   
Similarly, when assessing the FIT measure of PA (compliance to ACSM PA guidelines 
for aerobic exercise) in relation to elevated HOMA,  only the obese displayed statistically 
significant values in all activity groups (i.e., met ACSM guidelines, did not meet ACSM 
guidelines, and engagement in non-aerobic activity) when compared to those who did not 
engage in any physical activities.  This suggests that the obese might gain health benefits from 
any physical activity, even if attainment of existing ACSM physical activity recommendations 
does not occur.  Similar results were seen for the obese reaching >500 MET-Mins Per Week.  
Nelson and others (2003) using objective accelerometer data, established an association 
between time engaged in daily physical activity (measured in minutes) and lower insulin 
resistance49. This study suggests amount of time engaged in daily physical activity is an 
important determinant for improving glucose metabolism49. 
 
Immune System Cells.  Associations between this outcome and PA are suggestive but 
currently do not appear to be cohesive.  Vigorous intensity was associated with decreased rates 
of white blood cell count as well as segmented neutrophils (percent and number) when 
compared to individuals who reported no activity. Although this suggests engagement in activity 
with greater intensity decreases low-grade inflammation, the moderate intensity group displayed 
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higher immune system cell values compared to the non-activity group. Ad hoc comparisons 
revealed that percent and number of segmented neutrophils between the no activity group and 
the moderate intensity, as well as between the moderate versus vigorous intensity group to be 
significant.   
Similarly, in categories of MET-Minutes Per Week, no positive linear trend was demonstrated for 
increasing MET-Minutes.  Instead percent monocyte and basophils actually increased with a 
rise in MET-Minutes Per Week. In post hoc analyses, these relationships were statistically 
significant.  Only those exceeding 500 MET-Minutes Per Week displayed lower immune cell 
values for WBC count, lymphocyte number, and segmented neutrophils (percent and number).  
Absence of a positive linear trend with increasing physical activity suggests either an artifact of 
data collection where participants incorrectly self-reported their activities, presence of 
intervariablity between individuals, or inconsistencies that are currently not well understood. 
Another possibility is that some cells in the circulating innate system are relatively immature 
and, might not respond to anti-inflammatory effects (i.e. physical activity) as might fully 
differentiated tissue-based cells50.  Thus, specificity is needed in regarding an immune cell 
which might promote or actually decrease inflammation. This consideration can be addressed in 
future analyses with analysis of activation markers on immune cells or their capacity to release 
pro-inflammatory factors. 
 Regarding the ACSM weekly recommendations for FIT physical activities, individuals 
who met the guidelines exhibited decreased WBC count as well as percent monocyte and 
basophil, and number segmented neutrophil and eosinophil. Again however, percent monocyte 
and basophils increased when individuals met ACSM guidelines, suggesting self-report bias or 
interindividual variability. The displayed decreases in white blood cell values in response to 
exercise in this study, has been suggested by other studies.  Neutrophil counts are enhanced 
following exercise, and exert anti-inflammatory effects such as the production of soluble TNF 
receptors or sTNFs, which bind circulating TNF-alpha which is a pro-inflammatory cytokine51-54. 
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Lower white blood cells also may be attributed to the indirect decreases in adipose tissue as 
physical activity increases.  Veronelli showed WBC count elevated in the obese, and changed 
only as a function of BMI change55-57.   
 Among those with normal weight, we observed that as waist circumference increased 
with WBC and percent segmented neutrophils, while percent lymphocyte  decreased. A strong 
correlation coefficient between waist circumference and WBC count was observed among 
normal-weight females.  In contrast, normal weight males exhibited no correlation between waist 
circumference and WBC count.  Among individuals of normal weight, as MET-Mins Per Week 
increased with percent monocyte, while WBC and percent segmented neutrophils decreased.  
In the overweight, as waist circumference increased, WBC count increased (significant in both 
sexes in stratified model), percent segmented neutrophils increased, while percent lymphocyte 
decreased. This trend was also seen in the obese group. Also among the overweight as MET-
Mins Per Week increased, WBC count decreased while percent monocyte increased. The 
obese displayed no correlations to immune cells and MET-Mins Per Week.  This could suggest 
that increased BMI decreases physical activity’s anti-inflammatory effect, and is dependent on 
weight change. 
 
Strengths and Limitations.   A key strength of our study is the use of a disease-free and non-
smoking population, eliminating many sources of confounding that might not be adequately 
controlled in multivariate analyses.  Also, having data from laboratory tests provides objective 
measures of insulin resistance.  Waist measurements taken by trained personnel also enhance 
validity of our analyses.  Limitations include self-reported physical activity, increasing the 
possibility inaccurate information. However, data were collected by well-trained study personnel 
administered the physical activity questionnaires in order to reduce errors of self-report. Further, 
our large sample size could offset some level of error in reporting.  Other limitations include 
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assuming modality of exercise into classifications of aerobic and non-aerobic physical activity, 
and being truly able to calculate volume of PA.  
 
Summary.  Our study suggests that a greater level of intensity is associated with the most 
favorable health status (lowered waist circumference and increased insulin sensitivity) among 
adults, supporting the need to emphasize intensity when prescribing exercise.  Benefits of 
physical activity were observed even among the normal weight, particularly regarding 
prevention of elevated waist circumference which is an emerging risk factor for diabetes.  To 
verify our findings, future studies should obtain objective physical activity measures to more 
accurately categorize physical activity history such as use of accelerometer or measuring 
cardiorespiratory output or VO2 Max.   It is also of interest to monitor specific measures of low-
grade inflammation that might be associated with physical inactivity, and to further inspect 
divergent results across cell types.   One example would be to collectively assess the levels of 
pro-inflammatory cytokines such as TNF-alpha with the percent and number of monocytes.  
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Table 1   Participant Characteristics: NHANES 2001-2006 Stratified by BMI Group 
 
 Normal  
18.5-24.9 
n=1774 
Overweight 
25.0-29.9 
n=2230 
Obese 
>30 
n=2081 
P 
Value1,2 
Age3 36.32 
 (12.40) 
40.38  
(12.44) 
41.15 
(12.62) 
<.001 
Sex 
Male  
Female 
 
  679 (25.2) 
1095 (32.3) 
 
1173 (43.6) 
1057 (31.2) 
 
  840 (31.2) 
1241 (36.6) 
 
 
<.001 
Smoking4 
      Never 
      Former 
 
1365 (30.3) 
408 (26.0) 
 
1604 (35.5) 
625 (39.8) 
 
1543 (34.2) 
536 (34.2) 
 
 
.001 
Education4 
     Less than High School 
     High School Grad/GED 
     Some College 
     College Grad or above 
 
328 (22.6) 
361 (27.3) 
510 (28.3) 
575 (38.2) 
 
576 (39.7) 
482 (36.4) 
641 (35.6) 
530 (35.2) 
 
548 (37.7) 
481 (36.3) 
650 (36.1) 
401 (26.6) 
 
 
 
 
<.001 
Race/Ethnicity4 
     Non-Hispanic White 
     Non-Hispanic Black 
     Mexican American 
     Other Race 
 
872 (33.2) 
295 (23.0) 
399 (24.3) 
208 (38.8) 
 
916 (34.8) 
443 (34.6) 
665 (40.6) 
206 (38.4) 
 
841 (32.0) 
543 (42.4) 
575 (35.1) 
122 (22.8) 
 
 
 
 
<.001 
HOMA3 
     <2.24 
     >2.2 
1.62 (1.31) 
671 (46.6) 
138 (10.1) 
2.79 (2.87) 
549 (38.1) 
500 (36.5) 
4.97 (5.46) 
221 (15.3) 
733 (53.5) 
 
 
<.001 
Met Syndrome4, 5 
      Yes 
      No 
      Indeterminate6 
Components(Elevated)3 
      Abdominal Obesity 
      Triglycerides 
      HDL Cholesterol  
      Blood Pressure 
      Fasting Glucose 
 
18 (4.1) 
1432 (47.3) 
319 (18.0) 
 
170 (5.4) 
126 (13.3) 
95 (16.0) 
151 (17.0) 
140 (15.2) 
 
136 (31.1) 
1141 (37.7) 
932 (41.9) 
 
1046 (33.4) 
393 (41.6) 
213 (35.9) 
331 (37.3) 
363 (39.5) 
 
283 (64.8) 
453 (15.0) 
1271 (61.2) 
 
1915 (61.2) 
426 (45.1) 
286 (48.1) 
405 (45.7) 
416 (45.3) 
 
 
 
<.001 
 
    <.001 
<.001 
<.001 
<.001 
<.001 
Immune System Cells3 
    
White blood cell count (SI)   6.80 7.08 7.61 <.001 
Lymphocyte % 30.26 30.52 30.46 .635 
Lymphocyte # 1.98 2.07 2.26 <.001 
Monocyte % 7.73 7.84 7.44 <.001 
Monocyte # 0.51 0.54 0.55 <.001 
Segmented neutrophils % 58.82 58.37 58.88 .188 
Segmented neutrophils # 4.09 4.23 4.56 <.001 
Eosinophils % 2.58 2.66 2.58 .374 
Eosinophils # .17 .18 .19 .001 
Basophils % .64 .65 .66 .276 
Basophils # .03 .04 .04 <.001 
1
 Pearson Chi-Square Test for categorical variables 
2
 One-Way ANOVA for continuous variables 
3
 Mean (SD) 
4
 n (%) 
5
 Categorization: Three of the following five criteria must be met: abdominal obesity (men > 40in, women >35in), elevated 
triglycerides (≥ 150mg/dL), low HDL cholesterol (men <40mg/dL, women <50mg/dL), hypertension (≥135/85mmHg), and high 
fasting glucose(≥100mg/dL) (3). 
6
 2 or more components were missing 
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Table 2 Health Status of NHANES Participants (2001-06) according to PA Status 
 
A. Intensity Level  
  
LEISURE-TIME PA AT MODERATE OR VIGOROUS LEVEL IN PAST 
30 d PAST 30 d 
 
  
None7 
n=2061 
 
Moderate  
n=1689 
 
Vigorous  
n=2252 
 
P-
Value1,2 
HOMA3,5  
    <2.24 
    >2.2 
3.66 (4.99) 
448 (31.5) 
519 (38.6) 
3.26 (3.86) 
386 (27.1) 
378 (28.1) 
2.64 (2.37) 
588 (41.4) 
446 (33.2) 
 
 
< .001 
MetS4 
    
Normal 928 (31.0) 739 (24.7) 1330 (44.4) < .001 
Metabolic Syndrome  166 (38.8) 140 (32.7) 122 (28.6) < .001 
Indeterminate8 915 (36.9) 783 (31.6) 781 (31.5) < .001 
Waist Circumference4 
     Normal 
     Elevated 
 
1184 (38.5) 
810 (29.0) 
 
995 (32.3) 
662 (23.7) 
 
898 (29.2) 
1320 (47.3) 
 
 
<.001 
Immune System Cells3,5 
    
White blood cell count (SI) 7.33 (2.19) 7.48 (2.62) 6.82 (1.91) < .001 
Lymphocyte % 30.46 (8.61) 29.59 (8.77) 31.04 (8.167) < .001 
Lymphocyte # 2.15 (.88) 2.14 (1.40) 2.05 (.64) .003 
Monocyte % 7.54 (2.09) 7.45 (2.12) 2.13 (.05) < .001 
Monocyte #  .54 (.18) .53 (.18) .53 (.17) .188 
Segmented neutrophils % 58.74 (9.83) 59.84 (9.93) 57.70 (9.25) < .001 
Segmented neutrophils # 4.39 (1.78) 4.56 (1.94) 4.02 (1.56) < .001 
Eosinophils % 2.66 (2.22) 2.49 (1.94) 2.67 (1.99) .011 
Eosinophils # .19 (.18) .18 (.16) .18 (.15) .028 
Basophils % .63 (.44) .65 (.44) .67 (.48) .039 
Basophils # .04 (.05) .04 (.06) .03 (.05) .007 
1
 Pearson Chi-Square Test for categorical variables 
2
 One-Way ANOVA for continuous variables 
3
 Mean (SD) 
4
 n (%) 
5
 Significant differences (p < .05) between groups found for:  HOMA = None vs Vig, and Mod vs Vig; MET-Min per week None vs 
Mod,  None vs Vig, and Mod vs Vig; White blood cell count = None vs Vig and Mod vs Vig; Lymphocyte % = None vs Mod 
and Mod vs Vig; Lymphocyte #  = None vs Vig and Mod vs Vig; Monocyte % = None vs Vig and Mod vs Vig; Segmented 
neutrophils % = all groups;  Segmented neutrophils # = all groups; Eosinophils % = None vs Mod and Mod vs Vig; 
Eosinophils # = None vs Vig; Basophils % = None vs Vig; Basophils # Mod vs Vig. 
6
 Index of energy expenditure calculated as the product of the number of METs associated with one or more physical activities 
and the numbers of minutes the activities were performed per week or per day. 
7
 Those who responded as ‘no’ to having engaged in either ‘vigorous’ or ‘moderate’ physical activity. 
8
 2 or more components were missing 
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B. Frequency, Intensity, and Time (FIT)    
 
  
 
LEISURE-TIME PA AT MODERATE OR VIGOROUS LEVEL IN PAST 30 d  
 
  
None8 
n=2124 
 
Non-Aerobic 
Only 
n=231 
 
Did not Meet 
ACSM Guideline5 
n=2729 
 
Met ACSM 
Guideline5 
n=1001 
 
P-
Value1,2 
 
HOMA3,7   
      <2.24 
      >2.2  
3.74 (5.08) 
457 (31.7) 
543 (39.6) 
3.13 (3.91) 
62 (4.3) 
61 (4.4) 
2.98 (3.19) 
671 (46.6) 
581 (42.4) 
2.59 (2.50) 
251 (17.4) 
186 (13.6) 
< .001 
MetS2 
     
       Normal 949 (31.4%) 126 (4.2%) 1412 (46.7%) 539 (17.8%)  
       Metabolic Syndrome  172 (39.4%) 23 (5.3%) 180 (41.2%) 62 (14.2%)  
       Indeterminate9 949 (37.6%) 78 (3.1%) 1102 (43.7%) 393 (15.6%) < .001 
Waist Circumference2 
       Normal 
       Elevated 
 
822 (29.2) 
1225 (39.1%) 
 
120 (4.3) 
107 (3.4%) 
 
1339 (47.6) 
1346 (43.0%) 
 
530 (18.9) 
453 (14.5%) 
 
 
< .001 
Immune System Cells3,7 
     
  White blood cell count (SI) 7.33 (2.19) 7.01 (2.41) 7.18 (2.34) 6.91 (1.98) < .001 
  Lymphocyte %  30.45 (8.61) 29.49 (8.77) 30.30 (8.81) 30.93 (8.53) .085 
  Lymphocyte #  2.15 (.87) 2.03 (1.33) 2.10 (1.12) 2.06 (.64) .073 
  Monocyte % 7.54 (2.09) 7.74 (2.24) 7.67 (2.11) 7.92 (2.19) < .001 
  Monocyte # .54 (.18) .52 (.18) .53 (.17) .53 (.17) .437 
  Segmented neutrophils % 58.77 (9.84) 59.40 (9.60) 58.81 (9.55) 57.94 (9.77) .058 
  Segmented neutrophils # 4.40 (1.78) 4.22 (1.68) 4.30 (1.79) 4.10 (1.66) < .001 
  Eosinophils % 2.65 (2.21) 2.76 (2.00) 2.58 (2.04) 2.57 (1.76) .430 
  Eosinophils # .19 (.18) .19 (.16) .18 (.16) .17 (.13) .018 
  Basophils % .63 (.44) .66 (.43) .65 (.45) .69 (.49) .017 
  Basophils # .04 (.05) .04 (.05) .04 (.05) .04 (.05) .762 
1
 Pearson Chi-Square Test for categorical variables 
2
 One-Way ANOVA for continuous variables 
3
 Mean (SD) 
4
 n (%) 
5
 ACSM recommendations:  ≥ 5 days per week of moderate intensity physical activity for ≥30 min, or, ≥  3 days per week of 
vigorous intensity physical activity for ≥ 20 min(16) 
6
 Index of energy expenditure calculated as the product of the number of METs associated with one or more physical activities 
and the numbers of minutes the activities were performed per week or per day. 
7
 Significant differences (p < .05) between groups found for: HOMA = None vs Did not meet ACSM; and; None vs Met ACSM;  
White blood cell count = None vs Met ACSM and Did not meet ACSM vs Met ACSM; Monocyte % = None vs Met ACSM; 
Segmented neutrophils # = None vs Met ACSM and Did not meet ACSM vs Met ACSM; Eosinophils # = None vs met 
ACSM; Basophils = % None vs met ACSM. 
8
 Those who responded as ‘no’ to having engaged in either ‘vigorous’ or ‘moderate’ physical activity. 
9
 2 or more components were missing 
 
 
  
25 
 
 
 
C. Metabolic Equivalent Volume (MET-Minutes per Week) 
 
 
 
LEISURE-TIME PA AT MODERATE OR VIGOROUS LEVEL IN PAST 30 d 
 
 
 
None7 
 
< 2505 
 
250-499 
 
500+ 
 
P-Value1,2 
 
HOMA3,6 
      <2.24 
      >2.2 
3.74 (5.08) 
457 (31.7) 
543 (39.6) 
 
3.37 (4.07) 
190 (13.2) 
189 (13.8) 
2.85 (3.09) 
142 (9.9) 
114 (8.3) 
2.76 (2.70) 
652 (45.2) 
525 (38.3) 
< .001 
 
<.001 
MetS4 
     Normal 
 
949 (31.4) 
 
370 (12.2) 
 
280 (19.3) 
 
1427 (47.2) 
 
     Metabolic Syndrome 172 (39.4) 63 (14.4) 49 (11.2) 153 (35.0) < .001 
     Indeterminate8 949 (37.6) 363 (14.4) 228 (9.0) 982 (38.9)  
Waist Circumference3 
     Normal 
     Elevated 
 
822 (29.2) 
1125 (39.1%) 
 
338 (12.0) 
459 (14.7%) 
 
247 (8.8) 
306 (9.8%) 
 
1404 (49.9) 
1141 (36.4%) 
 
 
< .001 
Immune System Cells3,6 
     White blood cell count (SI) 
 
7.33 (2.19) 
 
7.49 (2.31) 
 
7.20 (2.19) 
 
6.96 (2.25) 
 
< .001 
     Lymphocyte % 30.45 (8.61) 29.43 (8.49) 30.29 (8.27) 30.75 (8.48) .002 
     Lymphocyte # 2.15 (.87) 2.10 (.62) 2.10 (.62) 2.08 (1.20) .158 
     Monocyte % 7.53 (2.09) 7.36 (2.12) 7.63 (2.02) 7.88 (2.16) < .001 
     Monocyte # 0.54 (.18) 0.53 (.18) 0.53 (.17) 0.53 (.17) .532 
     Segmented neutrophils % 58.77 (9.84) 60.01 (9.80) 58.85 (9.42) 58.15 (9.56) < .001 
     Segmented neutrophils # 4.40 (1.78) 4.60 (1.98) 4.34 (1.85) 4.12 (1.64) < .001 
     Eosinophils % 2.65 (2.21) 2.56 (2.13) 2.61 (2.25) 2.60 (1.85) .710 
     Eosinophils # 0.19 (.18) 0.19 (.18) 0.18 (.19) 0.18 (.14) .036 
     Basophils % 0.63 (.44) 0.63 (.41) 0.65 (.47) 0.67 (.47) .020 
     Basophils # 0.04 (.05) 0.04 (.05) 0.04 (.06) 0.04 (.05) .918 
1
 Pearson Chi-Square Test for categorical variables 
2
 One-Way ANOVA for continuous variables 
3
 Mean (SD) 
4
 n (%) 
5
 Index of energy expenditure calculated as the product of the number of METs associated with one or more physical activities and 
the numbers of minutes the activities were performed per week or per day. Recommended target volume in MET/min/wk is 500–
1000 MET/min/wk as recommended by the ACSM (16) 
6
 Significant differences (p < .05) between groups found for: HOMA = None vs 250 to <499, None vs 500, and <250 vs >500; White 
blood cell count = None  vs >500, and <250 vs >500; Lymphocyte % = None  vs <250, and <250 vs >500; Monocyte % = None  
vs >500 and <250 vs >500;  Segmented neutrophils % = None vs <250, and  <250 vs >500; Segmented neutrophils # = None  
vs  <250, None vs > 500, <250 vs >500, 250 to <500 vs >500; Eosinophils # = None vs >500; Basophils % None vs >500. 
7
 Those who responded as ‘no’ to having engaged in either ‘vigorous’ or ‘moderate’ physical activity. 
8
 2 or more components were missing 
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Table 3   ORs and 95% CIs for Insulin Resistance (HOMA > 2.2) in relation to PA and 
stratified by BMI Group 
 
   
Crude 
OR (95% CI) 
 
Age and Sex Adjusted 
OR (95% CI) 
 
Intensity Level 
Normal  
 
 
None1 
Moderate  
Vigorous  
 
 
1.00 
0.92 (.58-1.46) 
0.72 (.47-1.12) 
 
1.00 
0.94 (.59-1.50) 
0.70 (.45-1.09) 
Overweight None 
Moderate  
Vigorous  
1.00 
0.95 (.70-1.30) 
0.80 (.60-1.07) 
1.00 
0.95 (.69-1.31) 
0.76 (.57-1.02) 
Obese None 
Moderate  
Vigorous  
1.00 
0.67 (.46-.98) 
0.66 (.46-.96) 
1.00 
0.66 (.45-.96) 
0.59 (.40-.87) 
FIT2 
Normal weight 
 
None 
Non-Aerobic Only 
Did not meet ACSM 
Met ACSM 
 
 
1.00 
0.42 (.12-1.43) 
0.88 (.56-1.33) 
0.70 (.40-1.24) 
 
1.00 
0.39 (.11-1.34) 
0.87 (.58-1.32) 
0.69 (.39-1.22) 
 
Overweight None 
Non-Aerobic Only 
Did not meet ACSM 
Met ACSM 
 
1.00 
1.01 (.55-1.88) 
0.86 (.66-1.13) 
0.68 (.47-.99) 
1.00 
0.92 (.49-1.72) 
0.84 (.64-1.11) 
0.65 (.45-.95) 
Obese None 
Non-Aerobic Only 
Did not meet ACSM 
Met ACSM 
 
1.00 
0.81 (.38-1.71) 
0.65 (.46-.91) 
0.63 (.40-1.01) 
1.00 
0.65 (.30-1.38) 
0.61 (.43-.86) 
0.60 (.38-.96) 
 
MET-Min Per Week3 
Normal  
 
 
None 
<250 
250 to 499 
>500  
 
1.00 
0.74 (.40-1.40) 
0.82 (.42-1.60) 
0.82 (.54-1.24) 
 
1.00 
0.74 (.40-1.40) 
0.82 (.42-1.60) 
0.80 (.53-1.22) 
Overweight None 
<250 
250 to 499 
>500  
1.00 
0.94 (.63-1.40) 
0.84 (.54-1.31) 
0.79 (.60-1.04) 
1.00 
0.96 (.64-1.43) 
0.84 (.53-1.31) 
0.75 (.56-.99) 
Obese None 
<250 
250 to 499 
>500 
1.00 
0.67 (.43-1.06) 
0.58 (.33-1.01) 
0.66 (.47-.94) 
1.00 
0.67 (.43-1.06) 
0.59 (.34-1.03) 
0.59 (.41-.84) 
1
 Those who responded as ‘no’ to having engaged in either ‘vigorous’ or ‘moderate’ physical activity. 
2
 ACSM recommendations: ≥ 5 days per week of moderate intensity physical activity for ≥ 30 min, or, ≥ 3 days per week of 
vigorous intensity physical activity for ≥ 20 min. (16) 
3
 Index of energy expenditure calculated as the product of the number of METs associated with one or more physical activities and 
the numbers of minutes the activities were performed per week or per day. Recommended target volume in MET/min/wk is 500–
1000 MET/min/wk as recommended by the ACSM (16) 
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Table 4  ORs and 95% CIs for Sex-Specific At-Risk Waist Circumference in relation to 
PA 
 
   
Crude 
OR (95% CI) 
 
Age and Sex-Adjusted 
OR (95% CI) 
 
Intensity Level 
Normal  
 
 
 
 
None1 
Moderate  
Vigorous  
 
 
1.00 
1.22 (.84-1.76) 
0.33 (.22-.51) 
 
1.00 
1.13 (.77-1.66) 
0.37 (.24-.57) 
 
Overweight None 
Moderate 
Vigorous  
1.00 
1.14 (.92-1.42) 
0.50 (.41-.62) 
1.00 
1.53 (1.21-1.94) 
1.59 (1.23-2.06) 
FIT2 
Normal weight 
 
None 
Non-Aerobic Only 
Did not meet ACSM 
Met ACSM 
 
1.00 
0.32 (.10-1.05) 
0.67 (0.47-0.95) 
0.58 (0.36-0.94) 
 
1.00 
1.67 (1.02-2.74) 
0.82 (.23-2.91) 
1.12 (.70-1.81) 
 
Overweight No mod/vig 
Non-Aerobic Only 
Did not meet ACSM 
Met ACSM 
1.00 
0.52 (.32-.82) 
0.77 (0.64-0.93) 
0.58 (0.45-0.75) 
1.00 
0.49 (.14-1.68) 
0.67 (.46-.97) 
0.60 (.37-.98) 
MET-Min Per Week3 
Normal Weight 
 
 
None 
<250 
250 to 499 
>500  
 
 
1.00 
0.86 (.53-1.41) 
1.01 (.60-1.70) 
.50 (.34-.72) 
 
 
1.00 
0.85 (.51-1.42) 
0.99 (.58-1.70) 
0.52 (.36-.77) 
 
Overweight None 
<250 
250 to 499 
>500 
1.00 
0.94 (.71-1.23) 
1.09 (.80-1.48) 
0.58 (.48-.71) 
 
1.00 
0.88 (.64-1.22) 
1.05 (.73-1.51) 
0.72 (.57-.90) 
 
 
1
 Those who responded in ‘no’ having engaged in either ‘vigorous’ or ‘moderate’ physical activity. 
2
 ACSM recommendations: ≥ 5 days per week of moderate intensity physical activity for ≥ 30 min, or, ≥ 3 days per week of 
vigorous intensity physical activity for ≥ 20 min. (16) 
3
 Index of energy expenditure calculated as the product of the number of METs associated with one or more physical activities and 
the numbers of minutes the activities were performed per week or per day. Recommended target volume in MET/min/wk is 500–
1000 MET/min/wk as recommended by the ACSM. (16) 
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Table 5  Age-Adjusted Correlation Coefficients1 of Immune System Cells with HOMA, Waist 
Circumference and MET-Minutes per Week according to BMI Group 
 
  
HOMA 
 
Waist 
Circumference 
 
MET-Mins Per Week 
 
Normal  
White Blood Cell Count 
Monocyte % 
Segmented Neutrophils % 
Eosinophils % 
Basophils % 
Lymphocyte % 
 
0.07 (.05) 
-0.06 (.11) 
0.02 (.54) 
-0.01 (.76) 
-0.10 (.01) 
-0.00 (.92) 
 
0.21 (< .01) 
-0.01 (.77) 
0.16 (<.01) 
-0.02 (.58) 
-0.03 (.38) 
-0.18 (<.01) 
 
-0.12 (<.01) 
0.15 (<.01) 
0.12 (<.01) 
0.05 (.17) 
0.03 (.40) 
0.09 (.02) 
Overweight 
White Blood Cell Count 
Monocyte % 
Segmented Neutrophils % 
Eosinophils % 
Basophils % 
Lymphocyte % 
 
0.09 (.00) 
-0.07 (.02) 
0.03 (.38) 
-0.05 (.13) 
-0.03 (.42) 
0.00 (.99) 
 
0.21 (<.01) 
0.01 (.85) 
0.18 (<.01) 
-.01 (.72) 
-0.04 (.17) 
-0.20 (<.01) 
 
-0.09 (.01) 
0.11 (<.01) 
-0.04 (.19) 
-0.04 (.21) 
0.01 (.77) 
0.03 (.37) 
Obese 
White Blood Cell Count 
Monocyte % 
Segmented Neutrophils % 
Eosinophils % 
Basophils % 
Lymphocyte % 
 
0.13 (.00) 
-0.06 (.05) 
0.03 (.44) 
-0.01 (.86) 
-0.01 (.71) 
-0.01 (.74) 
 
0.20 (<.01) 
-0.02 (.61) 
0.10 (<.01) 
-0.03 (.43) 
-0.00 (.93) 
-0.10 (<.01) 
 
-0.06 (.06) 
0.06 (.07) 
-0.03 (.34) 
-0.02 (.66) 
0.06 (.10) 
0.02 (.54) 
1 
 Pearson  Partial Correlation Coefficient (P-Value) 
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Table 6  Age-Adjusted Correlation Coefficients1 
Stratified by BMI and Sex  
  
White Blood Cell Count  
with Waist Circumference 
Normal  
       Male 
       Female 
 
0.01 (0.80)1 
0.31 (<.001) 
Overweight 
       Male 
       Female 
 
0.16 (<.001) 
0.22 (<.001) 
Obese 
       Male  
       Female 
 
0.19 (<.001) 
0.17 (<.001) 
1
 Pearson Partial Correlation Coefficient (P-Value) 
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Scatterplots for White Blood Cell Counts (SI) and Waist Circumference  
Stratified by BMI Group and Sex 
 
 
Figure 1A: 
 
 
rP =0.010, p=0.79 
 Figure 1B: 
  
31 
rP =0.309, p=<.001
 
 
 Figure 1C: 
  
32 
rP =0.157, p=<.001
 
 
 Figure 1D: 
  
33 
rP =0.222, p=<.001
 
 
 Figure 1E: 
  
34 
rP =0.190, p=<.001
 
 
 Figure 1F: 
35 
rP =0.167, p=<.001
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Fig. 2   List of Leisure-Time Activities coded in NHANES (2001-06) 
 
Aerobic Activities 
 
 
Non-Aerobic Activities 
Aerobics Bowling 
Baseball Fishing 
Basketball Gardening 
Bicycling Golf 
Dance Hunting 
Football Kayaking 
Hiking Push-Ups 
Hockey Sit-Ups 
Jogging Skating 
Racquetball Skiing-downhill 
Rowing                                                                                                                       Stretching
Running Weight Lifting 
Skiing-cross country Yard Work 
Soccer Horseback Riding 
Softball Martial Arts 
Stairclimbing Wrestling 
Swimming Yoga 
Tennis Cheerleading and Gymnastics 
Treadmill Children’s Games-Dodgeball, Kickball, etc 
Volleyball Skateboarding 
Walking Surfing 
Boxing Trampoline Jumping 
Frisbee Other 
Rope Jumping  
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Fig. 3  MET Values  
 
NHANES Code 
 
Activity 
 
Moderate 
 
Vigorous 
 
10 Aerobics 5.0 7.0 
11 Baseball 5.0 6.0 
12 Basketball 6.0 8.0 
13 Bicycling  4.0 8.0 
14 Bowling 3.0 3.0 
15 Dance 4.5 6.0 
16 Fishing 3.5 6.0 
17 Football  5.0 8.0 
18 Gardening  4.0 5.0 
19 Golf  3.5 4.5 
20 Hiking  6.0 7.0 
21 Hockey  6.0 8.0 
22 Hunting  5.0 6.0 
23 Jogging  6.0 7.0 
24 Kayaking  3.5 7.0 
25 Push-ups  3.5 8.0 
26 Racquetball  7.0 10.0 
27 Rollerblading  6.0 7.0 
28 Rowing  3.5 7.0 
29 Running  7.0 10.0 
30 Sit-ups  3.5 8.0 
31 Skating  5.0 7.0 
32 Skiing – cross country  7.0 9.0 
33 Skiing – downhill  6.0 8.0 
34 Soccer  6.0 10.0 
35 Softball  5.0 6.0 
36 Stair Climbing  6.0 8.0 
37 Stretching  2.5 2.5 
38 Swimming  6.0 8.0 
39 Tennis  5.0 7.0 
40 Treadmill  4.5 7.0 
41 Volleyball  4.0 8.0 
42 Walking  3.5 5.0 
43 Weight Lifting  3.0 6.0 
44 Yard Work  4.0 6.0 
50 Boxing  6.0 9.0 
51 Frisbee  3.0 8.0 
52 Horseback Riding  4.0 6.5 
53 Martial Arts  4.0 10.0 
54 Wrestling  6.0 8.0 
55 Yoga  2.5 4.0 
56 Cheerleading and Gymnastics  4.0 6.0 
57 Children’s Dodgeball, Kickball, etc.  5.0 6.0 
58 Rope Jumping  8.0 10.0 
59 Skateboarding  5.0 6.0 
60 Surfing  3.0 5.0 
61 Trampoline Jumping  3.5 4.5 
71 Other  4.5 7.0 
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